Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience

Introduction The Bethesda System for Reporting Thyroid Cytology (BSRTC) refines the definition of and provides specific diagnostic criteria for fine-needle aspiration (FNA) assessment of thyroid lesions. This study was conducted to prospectively evaluate the diagnostic and clinical impact of using B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Society of Cytopathology JASC 2015-01, Vol.4 (1), p.25-29
Hauptverfasser: Kantola, Scott, MD, Virani, Nilam, MD, Haus, Carolyn, MD, Hipp, Jennifer, MD, PhD, Zhao, Lili, PhD, Jing, Xin, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 29
container_issue 1
container_start_page 25
container_title Journal of the American Society of Cytopathology JASC
container_volume 4
creator Kantola, Scott, MD
Virani, Nilam, MD
Haus, Carolyn, MD
Hipp, Jennifer, MD, PhD
Zhao, Lili, PhD
Jing, Xin, MD
description Introduction The Bethesda System for Reporting Thyroid Cytology (BSRTC) refines the definition of and provides specific diagnostic criteria for fine-needle aspiration (FNA) assessment of thyroid lesions. This study was conducted to prospectively evaluate the diagnostic and clinical impact of using BSRTC for management of thyroid lesions and to compare diagnostic performance of post-BSRTC period with that of pre-BSRTC period. Materials and methods The study included FNA specimens obtained in our institution 2.5 years prior to and 2.5 years after implementing BSRTC. Nondiagnostic rate, distribution of the diagnostic categories, rate of surgical follow-up, cytohistologic concordant rate, and risk of malignancy were calculated and compared between pre- and post-BSRTC periods. Results In comparison to the pre-BSRTC period, the post-BSRTC period generated a lower nondiagnostic rate (19.9% versus 15.8%), a greater proportion of benign (65.3% versus 69.2%) and atypia of undetermined significance or follicular lesion of undetermined significance (4.4% versus 7.4%) in contrast with a decreased proportion of follicular neoplasm or suspicious for follicular neoplasm categories (5.6% versus 2.2%). Rate of surgical follow-up decreased for benign (13.8% versus 7.6%) and atypia of undetermined significance or follicular lesion of undetermined significance (61.5% versus 42.1%) categories, and overall surgical rate reduced (24.2% versus 18.1%). Implementation of BSRTC did not affect overall rate of cytohistologic concordance (78.4% versus 80.5%) or the overall rate of histologically proven malignancy (30.6 versus 36.9%), whereas the individual cytohistologic concordant rate and the malignant rate for each of the diagnostic categories did not differ between pre- and post-BSRTC. Conclusions The implementation of BSRTC resulted in a decreased overall surgical rate, particularly for benign and follicular lesion of undetermined significance categories, without affecting overall cytohistologic concordance and rate of malignancy.
doi_str_mv 10.1016/j.jasc.2014.08.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229241082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S2213294514002166</els_id><sourcerecordid>2229241082</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-25433906cda5948473b7b7fee3f27fe41bffe3fa8679871403d1256bc0fd566f3</originalsourceid><addsrcrecordid>eNp9kUtv1DAUha2qiFalf4BF5SWbCX4kToJQpTLiJVUC0bK2HOe645DEqe2MyIbfjsMUVHWBF75ncc6R_V2EXlKSUULF6y7rVNAZIzTPSJURwo_QKWOUb1idF8eP9Ak6D6Ej6dQlYQV_jk44JQUVoj5Fv756FybQ0e4Bw171s4rWjdgZbIdJ6biqOdjxDscd4HeQ7tAqfLOECAM2zuNvMDkfV8ftbvHOtni7RDepuHO9u1veYDViO4Zo47xWqx7Dzwm8hVHDC_TMqD7A-cM8Q98_vL_dftpcf_n4eXt1vdG8FnHDipzzmgjdqqLOq7zkTdmUBoAblkZOG2OSVpUo66qkOeEtZYVoNDFtIYThZ-jVoXfy7n6GEOVgg4a-VyO4OUjGWM1ySiqWrOxg1YlM8GDk5O2g_CIpkSt62ckVvVzRS1LJhD6FLh7652aA9l_kL-hkeHswQPrl3oKXQf8h0Fqf6MvW2f_3Xz6J696OVqv-BywQOjf7BDZIKgOTRN6sy193n1AQlh7AfwOGwqva</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2229241082</pqid></control><display><type>article</type><title>Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience</title><source>Alma/SFX Local Collection</source><creator>Kantola, Scott, MD ; Virani, Nilam, MD ; Haus, Carolyn, MD ; Hipp, Jennifer, MD, PhD ; Zhao, Lili, PhD ; Jing, Xin, MD</creator><creatorcontrib>Kantola, Scott, MD ; Virani, Nilam, MD ; Haus, Carolyn, MD ; Hipp, Jennifer, MD, PhD ; Zhao, Lili, PhD ; Jing, Xin, MD</creatorcontrib><description>Introduction The Bethesda System for Reporting Thyroid Cytology (BSRTC) refines the definition of and provides specific diagnostic criteria for fine-needle aspiration (FNA) assessment of thyroid lesions. This study was conducted to prospectively evaluate the diagnostic and clinical impact of using BSRTC for management of thyroid lesions and to compare diagnostic performance of post-BSRTC period with that of pre-BSRTC period. Materials and methods The study included FNA specimens obtained in our institution 2.5 years prior to and 2.5 years after implementing BSRTC. Nondiagnostic rate, distribution of the diagnostic categories, rate of surgical follow-up, cytohistologic concordant rate, and risk of malignancy were calculated and compared between pre- and post-BSRTC periods. Results In comparison to the pre-BSRTC period, the post-BSRTC period generated a lower nondiagnostic rate (19.9% versus 15.8%), a greater proportion of benign (65.3% versus 69.2%) and atypia of undetermined significance or follicular lesion of undetermined significance (4.4% versus 7.4%) in contrast with a decreased proportion of follicular neoplasm or suspicious for follicular neoplasm categories (5.6% versus 2.2%). Rate of surgical follow-up decreased for benign (13.8% versus 7.6%) and atypia of undetermined significance or follicular lesion of undetermined significance (61.5% versus 42.1%) categories, and overall surgical rate reduced (24.2% versus 18.1%). Implementation of BSRTC did not affect overall rate of cytohistologic concordance (78.4% versus 80.5%) or the overall rate of histologically proven malignancy (30.6 versus 36.9%), whereas the individual cytohistologic concordant rate and the malignant rate for each of the diagnostic categories did not differ between pre- and post-BSRTC. Conclusions The implementation of BSRTC resulted in a decreased overall surgical rate, particularly for benign and follicular lesion of undetermined significance categories, without affecting overall cytohistologic concordance and rate of malignancy.</description><identifier>ISSN: 2213-2945</identifier><identifier>EISSN: 2213-2945</identifier><identifier>DOI: 10.1016/j.jasc.2014.08.003</identifier><identifier>PMID: 31051669</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>BSRTC ; Fine-needle aspiration ; Pathology ; Thyroid</subject><ispartof>Journal of the American Society of Cytopathology JASC, 2015-01, Vol.4 (1), p.25-29</ispartof><rights>American Society of Cytopathology</rights><rights>2015 American Society of Cytopathology</rights><rights>Copyright © 2015 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-25433906cda5948473b7b7fee3f27fe41bffe3fa8679871403d1256bc0fd566f3</citedby><cites>FETCH-LOGICAL-c396t-25433906cda5948473b7b7fee3f27fe41bffe3fa8679871403d1256bc0fd566f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31051669$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kantola, Scott, MD</creatorcontrib><creatorcontrib>Virani, Nilam, MD</creatorcontrib><creatorcontrib>Haus, Carolyn, MD</creatorcontrib><creatorcontrib>Hipp, Jennifer, MD, PhD</creatorcontrib><creatorcontrib>Zhao, Lili, PhD</creatorcontrib><creatorcontrib>Jing, Xin, MD</creatorcontrib><title>Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience</title><title>Journal of the American Society of Cytopathology JASC</title><addtitle>J Am Soc Cytopathol</addtitle><description>Introduction The Bethesda System for Reporting Thyroid Cytology (BSRTC) refines the definition of and provides specific diagnostic criteria for fine-needle aspiration (FNA) assessment of thyroid lesions. This study was conducted to prospectively evaluate the diagnostic and clinical impact of using BSRTC for management of thyroid lesions and to compare diagnostic performance of post-BSRTC period with that of pre-BSRTC period. Materials and methods The study included FNA specimens obtained in our institution 2.5 years prior to and 2.5 years after implementing BSRTC. Nondiagnostic rate, distribution of the diagnostic categories, rate of surgical follow-up, cytohistologic concordant rate, and risk of malignancy were calculated and compared between pre- and post-BSRTC periods. Results In comparison to the pre-BSRTC period, the post-BSRTC period generated a lower nondiagnostic rate (19.9% versus 15.8%), a greater proportion of benign (65.3% versus 69.2%) and atypia of undetermined significance or follicular lesion of undetermined significance (4.4% versus 7.4%) in contrast with a decreased proportion of follicular neoplasm or suspicious for follicular neoplasm categories (5.6% versus 2.2%). Rate of surgical follow-up decreased for benign (13.8% versus 7.6%) and atypia of undetermined significance or follicular lesion of undetermined significance (61.5% versus 42.1%) categories, and overall surgical rate reduced (24.2% versus 18.1%). Implementation of BSRTC did not affect overall rate of cytohistologic concordance (78.4% versus 80.5%) or the overall rate of histologically proven malignancy (30.6 versus 36.9%), whereas the individual cytohistologic concordant rate and the malignant rate for each of the diagnostic categories did not differ between pre- and post-BSRTC. Conclusions The implementation of BSRTC resulted in a decreased overall surgical rate, particularly for benign and follicular lesion of undetermined significance categories, without affecting overall cytohistologic concordance and rate of malignancy.</description><subject>BSRTC</subject><subject>Fine-needle aspiration</subject><subject>Pathology</subject><subject>Thyroid</subject><issn>2213-2945</issn><issn>2213-2945</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp9kUtv1DAUha2qiFalf4BF5SWbCX4kToJQpTLiJVUC0bK2HOe645DEqe2MyIbfjsMUVHWBF75ncc6R_V2EXlKSUULF6y7rVNAZIzTPSJURwo_QKWOUb1idF8eP9Ak6D6Ej6dQlYQV_jk44JQUVoj5Fv756FybQ0e4Bw171s4rWjdgZbIdJ6biqOdjxDscd4HeQ7tAqfLOECAM2zuNvMDkfV8ftbvHOtni7RDepuHO9u1veYDViO4Zo47xWqx7Dzwm8hVHDC_TMqD7A-cM8Q98_vL_dftpcf_n4eXt1vdG8FnHDipzzmgjdqqLOq7zkTdmUBoAblkZOG2OSVpUo66qkOeEtZYVoNDFtIYThZ-jVoXfy7n6GEOVgg4a-VyO4OUjGWM1ySiqWrOxg1YlM8GDk5O2g_CIpkSt62ckVvVzRS1LJhD6FLh7652aA9l_kL-hkeHswQPrl3oKXQf8h0Fqf6MvW2f_3Xz6J696OVqv-BywQOjf7BDZIKgOTRN6sy193n1AQlh7AfwOGwqva</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Kantola, Scott, MD</creator><creator>Virani, Nilam, MD</creator><creator>Haus, Carolyn, MD</creator><creator>Hipp, Jennifer, MD, PhD</creator><creator>Zhao, Lili, PhD</creator><creator>Jing, Xin, MD</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150101</creationdate><title>Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience</title><author>Kantola, Scott, MD ; Virani, Nilam, MD ; Haus, Carolyn, MD ; Hipp, Jennifer, MD, PhD ; Zhao, Lili, PhD ; Jing, Xin, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-25433906cda5948473b7b7fee3f27fe41bffe3fa8679871403d1256bc0fd566f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>BSRTC</topic><topic>Fine-needle aspiration</topic><topic>Pathology</topic><topic>Thyroid</topic><toplevel>online_resources</toplevel><creatorcontrib>Kantola, Scott, MD</creatorcontrib><creatorcontrib>Virani, Nilam, MD</creatorcontrib><creatorcontrib>Haus, Carolyn, MD</creatorcontrib><creatorcontrib>Hipp, Jennifer, MD, PhD</creatorcontrib><creatorcontrib>Zhao, Lili, PhD</creatorcontrib><creatorcontrib>Jing, Xin, MD</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Society of Cytopathology JASC</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kantola, Scott, MD</au><au>Virani, Nilam, MD</au><au>Haus, Carolyn, MD</au><au>Hipp, Jennifer, MD, PhD</au><au>Zhao, Lili, PhD</au><au>Jing, Xin, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience</atitle><jtitle>Journal of the American Society of Cytopathology JASC</jtitle><addtitle>J Am Soc Cytopathol</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>4</volume><issue>1</issue><spage>25</spage><epage>29</epage><pages>25-29</pages><issn>2213-2945</issn><eissn>2213-2945</eissn><abstract>Introduction The Bethesda System for Reporting Thyroid Cytology (BSRTC) refines the definition of and provides specific diagnostic criteria for fine-needle aspiration (FNA) assessment of thyroid lesions. This study was conducted to prospectively evaluate the diagnostic and clinical impact of using BSRTC for management of thyroid lesions and to compare diagnostic performance of post-BSRTC period with that of pre-BSRTC period. Materials and methods The study included FNA specimens obtained in our institution 2.5 years prior to and 2.5 years after implementing BSRTC. Nondiagnostic rate, distribution of the diagnostic categories, rate of surgical follow-up, cytohistologic concordant rate, and risk of malignancy were calculated and compared between pre- and post-BSRTC periods. Results In comparison to the pre-BSRTC period, the post-BSRTC period generated a lower nondiagnostic rate (19.9% versus 15.8%), a greater proportion of benign (65.3% versus 69.2%) and atypia of undetermined significance or follicular lesion of undetermined significance (4.4% versus 7.4%) in contrast with a decreased proportion of follicular neoplasm or suspicious for follicular neoplasm categories (5.6% versus 2.2%). Rate of surgical follow-up decreased for benign (13.8% versus 7.6%) and atypia of undetermined significance or follicular lesion of undetermined significance (61.5% versus 42.1%) categories, and overall surgical rate reduced (24.2% versus 18.1%). Implementation of BSRTC did not affect overall rate of cytohistologic concordance (78.4% versus 80.5%) or the overall rate of histologically proven malignancy (30.6 versus 36.9%), whereas the individual cytohistologic concordant rate and the malignant rate for each of the diagnostic categories did not differ between pre- and post-BSRTC. Conclusions The implementation of BSRTC resulted in a decreased overall surgical rate, particularly for benign and follicular lesion of undetermined significance categories, without affecting overall cytohistologic concordance and rate of malignancy.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>31051669</pmid><doi>10.1016/j.jasc.2014.08.003</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2213-2945
ispartof Journal of the American Society of Cytopathology JASC, 2015-01, Vol.4 (1), p.25-29
issn 2213-2945
2213-2945
language eng
recordid cdi_proquest_miscellaneous_2229241082
source Alma/SFX Local Collection
subjects BSRTC
Fine-needle aspiration
Pathology
Thyroid
title Prospective evaluation of impact of using the Bethesda System for Reporting Thyroid Cytopathology: an institutional experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T21%3A43%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prospective%20evaluation%20of%20impact%20of%20using%20the%20Bethesda%20System%20for%20Reporting%20Thyroid%20Cytopathology:%20an%20institutional%20experience&rft.jtitle=Journal%20of%20the%20American%20Society%20of%20Cytopathology%20JASC&rft.au=Kantola,%20Scott,%20MD&rft.date=2015-01-01&rft.volume=4&rft.issue=1&rft.spage=25&rft.epage=29&rft.pages=25-29&rft.issn=2213-2945&rft.eissn=2213-2945&rft_id=info:doi/10.1016/j.jasc.2014.08.003&rft_dat=%3Cproquest_cross%3E2229241082%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2229241082&rft_id=info:pmid/31051669&rft_els_id=1_s2_0_S2213294514002166&rfr_iscdi=true